Cas:140853-10-7 (DHQD)2PHAL manufacturer & supplier

Chemical Name:(DHQD)2PHAL

CAS.NO:140853-10-7

Synonyms:(9S,9”’S)-9,9′-[Phthalazine-1,4-diylbis(oxy)]bis(6′-methoxy-10,11-dihydrocinchonan);Hydroquinidine 1,4-phthalazinediyl ether;AD-mix-|A;(DHQD)PHAL;1,4-Bis(dihydroquinidine)phthalazine;(9S,9”’S)-9,9′-[1,4-Phthalazinediylbis(oxy)]bis(6′-methoxy-10,11-dihydrocinchonan);(DHQD)2-PHAL;(DHQD)2PHAL;Hydroquinidine 1,4-phthalazinediyl diether;AD-mix-ss;MFCD00198107;Cinchonan, 9,9′-[1,4-phthalazinediylbis(oxy)]bis[10,11-dihydro-6′-methoxy-, (9S,9”’S)-

Molecular Formula:C₄₈H₅₄N₆O₄

Molecular Weight:778.980

HS Code:2933990090

Physical and Chemical Properties:

Melting point:160ºC (dec.)

Boiling point:N/A

Density:1.3±0.1 g/cm3

Index of Refraction:1.688

PSA:94.96000

Exact Mass:778.420654

LogP:9.20

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (9S,9”’S)-9,9′-[Phthalazine-1,4-diylbis(oxy)]bis(6′-methoxy-10,11-dihydrocinchonan) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cinchonan, 9,9′-[1,4-phthalazinediylbis(oxy)]bis[10,11-dihydro-6′-methoxy-, (9S,9”’S)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,AD-mix-ss Use and application,AD-mix-ss technical grade,usp/ep/jp grade.

Related News: “It’s the achievement of a dream for an Italian company, I had chills,” he told Forbes in a Zoom interview on Thursday. “For the first three or four decades, my grandfather was in start-up mode [without] making money.” Ethanol, 2,2′-[(triethoxysilyl)imino]bis- manufacturers With over 80 years of experience developing and manufacturing small molecules, UQUIFA has not only the knowledge and tools to successfully execute transfer activities but also the track record of success with several crucial drug commercialization,” Gurnurkar says. butane-1,4-diylbis(dibenzylphosphine oxide) suppliers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. 8-(4-bromo-phenyl)-9-ethyl-1,3-dimethyl-3,9-dihydro-purine-2,6-dione vendor & factory With over 80 years of experience developing and manufacturing small molecules, UQUIFA has not only the knowledge and tools to successfully execute transfer activities but also the track record of success with several crucial drug commercialization,” Gurnurkar says. ,MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said.